Business Standard

Friday, December 20, 2024 | 11:07 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Pharma rally may lose steam as valuations factor in near term gains

Recovery in India business, traction in new launches in the US market are needed to sustain gains

pharmaceutical, pharma, testing, research, doctors, health, drugs, medicine, labaratory
Premium

A common thread across most pharma companies has been the reduction in operating expenditure and consequently higher operating leverage

Ram Prasad Sahu Mumbai
The rally in the BSE Healthcare index may lose steam after gaining 76 per cent since March lows. Nearly a fifth of these gains came over the last month. The recent gains came on the back of June quarter numbers and expectations of steady earnings growth going ahead. 

While the outsized gains over the last five months look sharp, the same has come after a continuous streak of underperformance every year since CY16. Says Pankaj Murarka of Renaissance Investment Managers, “The rerating has happened on expectations that earnings growth will come back in FY21, the defensive nature of the sector

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in